P04.1
Newborn affected by other maternal medication
Clinical Classification Guidelines
Excludes Type 1
- dysmorphism due to warfarin (Q86.2)
- fetal hydantoin syndrome (Q86.1)
Excludes Type 2
- maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
- maternal use of drugs of addiction (P04.4-)
Code First
- , if applicable, withdrawal symptoms from maternal use of drugs of addiction (P96.1)
- withdrawal symptoms from therapeutic use of drugs in newborn (P96.2)
Medical Intelligence & Overview
ICD-10 Code P04.1 refers to cases where newborns are affected by medications taken by their mothers during pregnancy or delivery. This condition highlights the potential impact maternal medication can have on a developing fetus or a newborn, emphasizing the importance of medical guidance during pregnancy. Recognizing and understanding this condition can help healthcare providers monitor and manage affected infants appropriately, ensuring their health and well-being.
Causes & Symptoms
Clinical Causes: Maternal use of medications during pregnancy, especially when medication is not prescribed or taken without medical supervision. Use of certain medications that can pass through the placenta to the fetus. Exposure to drugs that have known teratogenic or adverse effects on fetal development. Use of medications during labor that might affect the newborn post-delivery. Maternal misuse or abuse of medications, including over-the-counter drugs or illicit substances.
Key Symptoms: Respiratory distress or difficulty breathing Feeding problems or poor feeding Unusual irritability or lethargy Sleep disturbances Birth defects or congenital anomalies related to medication exposure Low or high birth weight Jaundice or skin discoloration Seizures or abnormal neurological signs
Diagnostic & Treatment
Diagnosis Path: Diagnosis of conditions related to maternal medication exposure involves a combination of medical history, including details about the medications taken during pregnancy, and clinical examination of the newborn. Additional testing, such as blood tests, genetic testing, or imaging studies, may be used to evaluate any underlying developmental issues. Healthcare providers often review maternal medication records and consider the timing, dosage, and type of medication to determine potential effects on the infant.
Treatment Protocols: Management of newborns affected by maternal medication involves supportive and symptomatic care. This may include respiratory support, nutritional assistance, and monitoring for any neurological or metabolic problems. Interdisciplinary approaches, involving pediatricians, neonatologists, and specialists, are often necessary to address specific conditions. Preventative strategies focus on counseling pregnant women about medication use, ensuring they follow medical advice to minimize risks.
Clinical Advice & FAQs
Billing Guidance
Is P04.1 a billable ICD-10 code?
Yes, P04.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P04.1?
Clinical documentation must specify the nature of Newborn affected by other maternal medication and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
